Skip to main content

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review

Abstract

COVID-19 caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originated in Wuhan (Hubei province, China) during late 2019. It has spread across the globe affecting nearly 21 million people with a toll of 0.75 million deaths and restricting the movement of most of the world population during the past 6 months. COVID-19 became the leading health, economic, and humanitarian challenge of the twenty-first century. In addition to the considerable COVID-19 cases, hospitalizations, and deaths in humans, several cases of SARS-CoV-2 infections in animal hosts (dog, cat, tiger, lion, and mink) have been reported. Thus, the concern of pet owners is increasing. Moreover, the dynamics of the disease requires further explanation, mainly concerning the transmission of the virus from humans to animals and vice versa. Therefore, this study aimed to gather information about the reported cases of COVID-19 transmission in animals through a literary review of works published in scientific journals and perform genomic and phylogenetic analyses of SARS-CoV-2 isolated from animal hosts. Although many instances of transmission of the SARS-CoV-2 have been reported, caution and further studies are necessary to avoid the occurrence of maltreatment in animals, and to achieve a better understanding of the dynamics of the disease in the environment, humans, and animals. Future research in the animal–human interface can help formulate and implement preventive measures to combat the further transmission of COVID-19.

Introduction

The outbreak of Coronavirus disease-2019 (COVID-19) leading to pneumonia of unknown origin was linked to the Huanan Seafood Wholesale Market located in the city of Wuhan, Hubei province, China [1, 2]. The pathogen was soon identified as a novel coronavirus named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease was referred to as Coronavirus disease-2019 (COVID-19) [3]. The SARS-CoV-2 is the third coronavirus that has emerged in the last two decades. Others are the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV), which emerged during 2002 and 2012, respectively [2, 4]. Compared to SARS-CoV and MERS-CoV, SARS-CoV-2 is responsible for the most significant economic loss and the highest number of infections and deaths [5]. Until 13 August 2020 around 21 million COVID-19 cases and over 0.75 million deaths have been reported. SARS-CoV-2 belongs to the order Nidovirales, suborder Coronavirineae, and family Coronaviridae. The family Coronaviridae contains two subfamilies named Lentovirinae and Orthocoronavirinae. The latter is further classified into four genera, namely Alphacoronavirus (αCoV), Betacoronavirus (βCoV), Gammacoronavirus (γCoV), and Deltacoronavirus (δCoV), as shown in Fig. 1. The γCoVs and δCoVs cause diseases in birds while αCoVs and βCoVs are mainly found in mammals such as bats, rodents, civets, pigs, horses, cattle and humans [6,7,8,9]. SARS-CoV-2 clusters with lineage βCoV together with SARS-CoV and MERS-CoV [8]; both originating from bats [1, 10, 11].

Fig. 1
figure1

Phylogenetic tree of Coronaviridae taxonomy

Coronaviruses are enveloped viruses with single-stranded positive-sense RNA (+ss) and genome size between 26 and 32 kb in length [12, 13]. These viruses possess four essential structural proteins: spike glycoprotein (S), matrix protein (M), envelope protein (E), and nucleocapsid protein (N) [13,14,15, 22]. According to the genomic analysis, SARS-CoV-2 shares a 96.2% identity with the genome of bat CoV; RaTG13, indicating a possible origin of the virus in bats [3, 16]. Several studies suggested that the pangolin could be the potential intermediate host involved in the evolution of the virus because of the unique receptor-binding domain configuration [17,18,19, 22].

Among the global fear due to the rapid spread of the COVID-19 and absence of specific treatment or vaccine, the first case of human-to-animal transmission was recorded in Hong Kong, where a 17-years-old Pomeranian dog was affected [20]. This case raised concerns about the possibility of SARS-CoV-2 transmission from humans to animals and vice versa, which would represent the difficulties in fighting the virus significantly. However, based on recently published findings, other authors hypothesized that an immunological cross-protection between SARS-CoV-2 and canine respiratory coronavirus (CRCoV) exists due to the high homology between the spike protein epitopes of the two taxonomically-related coronaviruses [21].

The objective of the present study was to gather, present, and discuss information on the reported cases of COVID-19 in animals focusing on the virus transmission cases in pets and perform genomic and phylogenetic analyses of SARS-CoV-2 isolated from animal hosts. Further studies on the dynamics of the disease are essential to adopt suitable control measures to reduce transmission of the virus.

Possible origin of the new coronavirus

To discuss the origin of SARS-CoV-2, it is necessary to analyze the source of other coronaviruses such as SARS-CoV and MERS-CoV, as shown in Fig. 2 [22]. SARS-CoV emerged in Guangdong province, Southern China, in November 2002 and was characterized as a contagious respiratory disease of humans [22, 23]. Records showed 8422 registered cases and 916 deaths in humans, spreading to 29 countries during the epidemic with a case fatality rate (CFR) of 9.6% [23]. Studies revealed the presence of several coronaviruses in species of horseshoe bats (genus Rhinolophus), which are evolutionarily related to SARS-CoV in their genome organization and sequence [24, 25]. In the further investigations of the initial SARS outbreak of 2002 in Hong Kong, it was recognized that cats (Felis domesticus) and ferrets (Mustela furo) could be infected with SARS-CoV [26].

Fig. 2
figure2

Coronavirus origins and relationship between humans and animals

In 2012, another coronavirus causing severe acute respiratory syndrome in humans was first reported in Saudi Arabia and was later called the Middle East respiratory syndrome coronavirus (MERS-CoV) [27]. MERS-CoV is βCoV of the C lineage with a genotype very similar to that of bats of the same line, such as BtCoV-HKU4 and BtCoVHKU5 [28].

The transmission of MERS-CoV to dromedaries was identified through the detection of specific antibodies against the virus in these animals [29]. According to Corman et al. [30], MERS-CoV has been circulating in dromedaries for more than 20 years [30]. Therefore, it can be assumed that bats are reservoirs for several coronaviruses, including SARS-CoV, MERS-CoV, and SARS-CoV-2 [25, 31, 32].

According to reports SARS-CoV-2 is closely related to SARS-CoV [33, 34] and the similarity between the genomes was about 80% [3, 16, 35]. Though SARS-CoV-2 has most likely originated from bats, it is not yet clear which animal served as an intermediate host and contributed towards the evolution of the virus before the spillover to humans occurred [22].

In another study, it was demonstrated that SARS-CoV-2 was a chimeric virus between a bat coronavirus and a coronavirus of unknown origin [36]. In a similar research, it was reported a novel bat-derived coronavirus, denoted RmYN02, identified from the metagenomic analysis of samples from 227 bats collected from Yunnan province in China between May and October 2019 [37]. Notably, RmYN02 shares a 93.3% nucleotide identity with SARS-CoV-2 at the scale of the complete genome and 97.2% identity in the ORF1ab gene. It could, therefore, be considered the closest relative of SARS-CoV-2 reported to date. In contrast, RmYN02 showed low sequence identity (61.3%) with SARS-CoV-2 in the receptor-binding domain (RBD), suggesting that RmYN02 might not bind to angiotensin-converting enzyme 2 (ACE2). Critically, and in a similar manner to SARS-CoV-2, RmYN02 was characterized by the insertion of multiple amino acids at the junction site of the S1 and S2 subunits of the spike (S) protein. This provides strong evidence that such insertion events can occur naturally in animal βCoV [37, 39].

It can be seen that tiger SARS-CoV-2/USA/NY-040420 EPI_ISL_420293 shares 99.96% nucleotide identity with human SARS-CoV-2 reference genome at the complete genome-scale, followed by mink SARS-CoV-2/NB04 EPI_ISL_447634 (99.90%), mouse SARS-CoV-2/HRB-26 m EPI_ISL_459910 (99.87%), cat SARS-CoV-2 EPI_ISL_437349 (99.85%), and dog SARS-CoV-2/HKG/20-03695/2020 (99.51%) demonstrating a high level of nucleotide identity between SARS-CoV-2 isolates from domestic animals and humans (Table 1).

Table 1 Whole-genome nucleotide identity percent among different representative coronaviruses and human SARS-CoV-2

Also, noteworthy is the shared identity between tiger SARS-CoV-2/USA/NY-040420 EPI_ISL_420293 and mink SARS-CoV-2/NB04 EPI_ISL_447634 (99.89%), cat SARS-CoV-2 EPI_ISL_437349 and tiger SARS-CoV-2 USA NY-040420 EPI_ISL_420293 (99.84%), cat SARS-CoV-2 EPI_ISL_437349 and mink SARS-CoV-2/NB04 EPI_ISL_447634 (99.78), cat SARS-CoV- 2 EPI_ISL_43734 and dog SARS-CoV-2/HKG/20-03695/2020 (99.39%), tiger SARS-CoV-2/USA/NY/040420 EPI_ISL_420293 and dog SARS-CoV-2/HKG/20-03695/2020 (99, 54%), and dog SARS-CoV-2/HKG/20-03695/2020 and mink SARS-CoV-2/NB04 EPI_ISL_447634 (99.53%) (Table 1).

Regarding the percentage of nucleotide identity of the spike protein, dog SARS-CoV-2/HKG/20-03695/2020, tiger SARS-CoV-2 USA NY-040420 EPI_ISL_420293, and cat SARS-CoV-2 EPI_ISL_437349 share 99.97% with human SARS-CoV-2 (Table 2).The amino acid identity of the spike protein between dog SARS-CoV-2/HKG/20-03695/2020, tiger SARS-CoV-2 USA NY-040420 EPI_ISL_42029 and cat SARS-CoV-2 EPI_ISL_437349 with SARS-CoV-2 is 99.92% (Table 3).

Table 2 Spike gene nucleotide identity percent among different representative coronaviruses and human SARS-CoV-2
Table 3 Spike protein amino acid identity percent among different representative coronaviruses and human SARS-CoV-2

However, the spike protein amino acid and nucleotide identity among tiger SARS-CoV-2/USA/NY/040420 EPI_ISL_42029, dog SARS-CoV-2/HKG/20-03695/2020, and cat SARS-CoV-2 EPI_ISL_437349 was 100% (Tables 2 and 3).

This result seems to be related to animal species that have been infected by SARS-CoV-2 through humans (dog, cat, and tiger, at first). Transmission to humans does not seem so likely, however, given the identity between nucleotides and amino acids of the spike protein, transmission between animals seem possible. Because it has a similar genome to other animal coronaviruses, SARS-CoV-2 may have undergone nucleotide mutation when transmitted to animals, expressing amino acids that increased its pathogenicity in animals, especially those related to spike protein [38, 39].

The RBD of SARS-CoV-2 spike protein, which lies in the S1 domain, is a critical element for determining the susceptibility of the new host species. The studies performed on the interaction between the viral RBD with host cellular receptor (ACE2) revealed snakes, pangolins, and turtles as the potential intermediate hosts [40]. Turtles, along with other animal species, are favored animals in the Huanan Seafood Wholesale Market. However, extended studies are needed to prove their associations scientifically [11].

One of the probable intermediate hosts for SARS-CoV-2 is a pangolin. Pangolin-CoV has 91.02% and 90.55% identity to SARS-CoV-2 and BatCoV RaTG13, respectively [33, 35]. Furthermore, the SARS-CoV-2 spike proteins RBD resembles closely Malayan pangolin CoV (Pangolin-CoV) [40]. These findings suggested that pangolins can be the intermediate host for SARS-CoV-2 transmission. Further research is necessary to confirm the origin and transmission dynamics of SARS-CoV-2.

Positive aspects of coronaviruses transmission from animals to humans

The possible protective effect of pet-ownership against coronaviruses warrants consideration where coronavirus prevalence is high across the pet population. Canine respiratory coronaviruses often occur among dogs. Ownership of an infected pet can lead to the transmission of viruses from animals to humans. Although possible protection caused by the possession of a pet has not yet been found, the frequent occurrence of coronavirus in canines could help the human immune system develop a better response against SARS-CoV-2 [41].

Transmission of SARS-CoV-2 from COVID-19 positive persons to animals

At the beginning of the SARS-CoV-2 outbreak, it was thought that pets were not susceptible to the SARS-CoV-2. However, a natural infection of a cat was reported in Belgium with traces of the virus identified in the collected samples by PCR. This cat exhibited respiratory difficulty, vomiting, and diarrhea, which may indicate active replication of the virus inside the animal [39, 41, 42]. However, the animal was not examined by a veterinarian, so further evaluation such as serology was necessary. In another study, Shi et al. showed that cats could be not only naturally infected with SARS-CoV-2 but also that adolescent cats artificially inoculated with the virus presented severe histological lesions and died [18]. However, in further studies, dogs exhibited seroconversion, but the virus could not be isolated. The susceptibility of cats and ferrets to SARS-CoV-2 could be attributed to the ACE2 (SARS-CoV-2 receptors) [3, 43]. These receptors are expressed in type II pneumocytes serous epithelial cells of tracheobronchial submucosal glands in ferrets [44]. Moreover, the SARS-CoV-2 spike-contacting regions of ACE2 are similar in both ferrets and cats, differing by only two amino acids [5].

The previous reports have shown that SARS-CoV can infect ferrets and cats [26], which implies that ferrets and cats may also be susceptible to SARS-CoV-2. This possibility might be associated with cases of SARS-CoV-2 transmission to animals. In addition to probably sharing the same origin, bats have significant similarities among their genotypes [3, 25, 31, 32, 35, 36].

Based on SARS-CoV epidemiology, the COVID-19 pandemic raises the alarm that animals may become infected and become potential transmitters to humans. The fear of possible transmission of animals to humans and the fact that many residents were forced to leave their animals behind due to evacuation and quarantine, thinking that they would return soon, generated a large number of animal abandonment [45].

Authorities in Hunan and Zhejiang provinces of China also announced that they would start killing pets found in public to prevent the transmission of the virus. This concern intensified in late February 2020, when dogs in Hong Kong tested positive for the new coronavirus, being considered the first known case of transmission of COVID-19 from humans to animals later, felines [20, 39, 46, 47].

In a recent study, it was investigated the possible protection conferred by previous exposure of individuals to naturally infected animals with coronaviruses taxonomically related to the circulating SARS-CoV-2 [21, 41, 48,49,50].

The animals were experimentally infected by SARS-CoV-2 via the intranasal route through the receptor ACE2 [51]. Several studies report the use of ACE2 by the new coronavirus as its receptor for cell entry [3, 43]. Dogs were also inoculated, although seroconversion was observed, no virus could be isolated from the inoculated and uninoculated contacts. Further, ferrets showed equal susceptibility to cats, while pigs, chicken, and ducks were found referent to vulnerability [5].

Until now, studies based on RBD domain analysis ruled out the probability of mice, rats, and rabbit’s involvement in the SARS-CoV-2 cycle [52]. The findings on ferrets, orangutans, and monkeys showed a higher affinity of ACE2 with the RBD domain of SARS-CoV-2 S protein [53]. A codon-usage based analysis pointed to snakes as a probable host, although these findings were contradicted by subsequent studies [54].

Some researchers revealed that cats could naturally be infected with other coronaviruses such as feline coronavirus (FCoV) just as canines can be infected with canine coronavirus (CCoV) [55, 56]. These animals probably get infection once the virus binds to the receptor, ACE2 [51].

Another research group conducted a retrospective serological survey on cats infected with SARS-CoV-2 in Wuhan, China. The authors collected 102 samples after the emergence of COVID-19 and included 39 samples collected before the outbreak. Fifteen (14.7%) of 102 serum samples collected after the outbreak were positive for antibodies against the SARS-CoV-2 receptor-binding domain (RBD) by ELISA test. Among the positive samples, 11 had neutralizing antibodies to SARS-CoV-2 with a titer ranging from 1/20 to 1/1080. Twenty-nine out of the 39 serum samples collected before the outbreak were negative. However, no cat that tested positive on serological tests showed any clinical signs. No serological cross-reactivity was detected between SARS-CoV-2 and type I or II of the feline infectious peritonitis virus (FIPV). As the authors suggested, the cat population studied in Wuhan was infected with SARS-CoV-2 after the beginning of the outbreak [57]. In France, a group of 18 veterinary students investigated the spread of the new coronavirus in 21 pets (9 cats and 12 dogs). Eleven cases showed symptoms compatible with COVID-19, while only two confirmed positive for the new coronavirus. Although three of these cats showed clinical signs of respiratory or gastrointestinal disease, no animal was considered positive by RT-PCR or by the presence of specific antibodies to SARS-CoV-2 [51].

In a separate study, the researchers demonstrated that ferrets, cats, and dogs could be experimentally infected by SARS-CoV-2 via the intranasal route [40]. Several studies reported that the SARS-CoV-2 uses the same receptor, ACE2, to enter the respiratory mucosa [3, 5, 43]. This probably indicates the possibility of transmission of SARS-CoV-2 from humans to animals. In a recent experimental study, it was observed that cats infected with SARS-CoV-2 could transmit the virus to naïve cats that come into contact with them [58]. However, whether they can transmit the virus to humans or else, humans can transmit the virus to pets, or other animals are not yet fully understood.

Also, the first non-domesticated animal case of SARS-CoV-2 transmission was from a big cat, Nadia, and a 4-year-old Malayan tiger infected from the COVID-19 positive workers at the Bronx Zoo, New York, United States. This was the first known animal infection in the US and a tiger anywhere in the world, and was confirmed by the US Department of Agriculture (USDA), the US Centers for Disease Control and Prevention (CDC), National Veterinary Services Laboratories, and the Wildlife Conservation Society (WCS) [54, 59, 60]. Consequently, COVID-19 was detected in four tigers and three lions. Mild infection of respiratory distress was also noted in two pet cats in the USA [61].

A new case was reported in Moskva, Moskovskaya Oblast, Russia, where a 5-year-old cat tested positive for SARS-CoV-2. Samples (throat and nasal swabs) were taken from the suspect cat to detect SARS-CoV-2. The lab tests were performed using RT-PCR in real-time with electrophoretic detection of amplification products. The obtained amplification reaction product was sequenced using selected specific primers flanking a 232 bp N gene fragment (ORF1ab) of the SARS-CoV-2. The tests showed 100% identity of the analyzed fragment of the N gene ORF1ab of the SARS-CoV-2. The animals were quarantined [62].

It was previously shown that SARS-CoV does not infect or cause disease in poultry. Because the COVID-19 virus belongs to the same group as SARS-CoV and uses the same ACE2 host cell receptor, it is highly unlikely that poultry is susceptible to COVID-19. Still, it remains to be scientifically proven [63].

For the phylogenetic analysis, complete genome sequences of the viruses falling in the Betacoronavirus genus were retrieved from NCBI GenBank. The sequences involve SARS-CoV and SARS-CoV-2 of Sarbecovirus subgenus and few of the sequences from different animal species including the dog, mink, rabbit, rat, pangolin, hedgehog, camel, bats, and wild and domestic felines comprising subgenuses Merbecovirus, Embecovirus, Hibecovirus and Nobecovirus within the genus Betacoronavirus (Fig. 3). The sequence alignment was done with ClustalW in MEGA 6.02 software, and phylogeny was constructed using the GTR + G + I substitution model applying the maximum likelihood method. In the analysis, canine and feline CoVs of Alphacoronavirus were taken as the outgroup for constructing a phylogenetic tree of Betacoronavirus. All the CoVs of genus Betacoronavirus clustered in their respective subgenus clades. Notably, the mink and tiger virus isolates showed 99.6–99.9% homology with human SARS-CoV-2 isolates from different parts of the world. Contrarily, the canine Betacoronavirus (CRCoV) from subgenus Embecovirus showed 45.8–46.2% similarity with SARS-CoV-2. Furthermore, pangolin CoV, SARS-like bat CoVs, and bat CoVs (RaTG13 strain) showed homology between 86.6 and 96.3% with SARS-CoV-2. The camel isolate of MERS-CoV showed a 51% similarity with SARS-CoV-2 at the nucleotide level (Fig. 3). Our analysis demonstrated a high divergence between animal origin CoVs and SARS-CoV-2 except for a few strains which were isolated from mink and tiger as were the cases of COVID-19 infected persons.

Fig. 3
figure3

Phylogenetic analysis of human and animal CoVs

Auspicious mode of transmission of SARS-CoV-2 from humans to animals

Though the exact ways of transmission of SARS-CoV-2 from infected humans to animals are vaguely understood, the possible and promising transmission may occur through touching their noses or mouth by infected hands defiled with respiratory droplets or saliva [64]. At the time of sneezing, coughing, or even talking, infected humans can disseminate respiratory droplets, which have a pivotal role in the transmission of the virus to animals [65]. However, the transmission of the virus from affected people can be facilitated by some favorable risk factors, e.g., kissing, petting, licking, or hugging pet animals [66].

Case of animal-to-human transmission of coronavirus at a mink farm in the Netherlands

According to the government of the Netherlands, through a letter issued by the Ministry of Agriculture, Nature and Food Quality, it is possible that an employee who worked on a mink farm infected with SARS-CoV-2 contracted the virus, having already been recovered from the disease. Also, research shows that minks can be asymptomatic and that cats play an important role in the potential transfer of viruses between investigated farms [67].

Conclusions

There are multiple studies on the origin of coronaviruses and their zoonotic potential. Some coronaviruses that infect animals can sometimes be spread to humans and then spread between people as happened in the case of MERS and SARS. This is also what happened with the virus that caused the current outbreak of COVID-19. However, the exact origins of this virus are still unclear. The scientific community has put significant effort into identifying the source of SARS-CoV-2, and to date, genetic evidence suggests that it was likely acquired from bats. The first infections were linked to a live animal market in Wuhan, suggesting a zoonotic origin. The virus is now spreading from person to person and caused one of the most significant pandemics of the recent era. Infection with SARS-CoV-2 has been reported in several animals through serological and molecular analyses and experimental inoculations. However, it is not proved that animals can transmit SARS-CoV-2 to humans and to what extent humans can transmit this virus to animal species. Veterinary public health officials and designated public health officials should work to determine whether animals should be tested for SARS-CoV-2 when the animals are in the same environment as infected owners using a One Health approach. Available information suggests that the risk of SARS-CoV-2 spread from animals to humans is low. Even though human-to-animal transmission or vice versa is possible, caution and effective communication with the pet owners are necessary to prevent the abandonment and death of animals indiscriminately. Although a case of SARS-CoV-2 transmission from animals to humans has already been reported, this is only a report, so further research is needed before declaring that animals can transmit the new coronavirus to humans. Geographic information system (GIS) based on computer and information technology would be useful in analyzing the disease pattern. The collaborative global effort, such as “One-Human–Environmental–Animal Health,” is required to reduce the global risk of zoonotic diseases. Further studies are essential to understand better the origin of the virus and transmission dynamics, which will help educate people and avoid unnecessary discrimination to animals. Preventive measures that have proven to be effective should be encouraged, such as correct hygiene, social distance, and, if necessary, social isolation or quarantine. Good practices such as the use of footbaths, whirlpools, disinfection of urban areas, and sanitary barriers can be considered.

Availability of data and materials

All data analyzed or generated during this study are included in this publication and its additional files.

Abbreviations

COVID-19:

Coronavirus disease-2019

SARS-CoV-2:

Severe acute respiratory syndrome coronavirus 2

MERS-CoV:

Middle East respiratory syndrome coronavirus

αCoV:

Alphacoronavirus

βCoV:

Betacoronavirus

γCoV:

Gammacoronavirus

δCoV:

Deltacoronavirus

CRCoV:

Canine respiratory coronavirus

Kb:

Kilobase

CFR:

Case fatality rate

RBD:

Receptor-binding domain

ACE2:

Angiotensin-converting enzyme 2

PCR:

Polymerase chain reaction

ELISA:

Enzyme linked immunosorbent assay

FIPV:

Feline infectious peritonitis virus

RT-PCR:

Real-time polymerase chain reaction

USDA:

US Department of Agriculture

CDC:

US Centers for Disease Control and Prevention

WCS:

National Veterinary Services Laboratories and the Wildlife Conservation Society

IBV:

Infectious bronchitis vírus

NCBI:

National Center for Biotechnology Information

GIS:

Geographic information system

References

  1. 1.

    Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  2. 2.

    Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395(10223):470–3. https://doi.org/10.1016/s0140-6736(20)30185-9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020. https://doi.org/10.1016/j.ijantimicag.2020.105924.

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med. 2020;382(8):692–4.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  5. 5.

    Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science. 2020;368(6494):1016–20.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  6. 6.

    Lau SK, Woo PC, Li KS, Tsang AK, Fan RY, Luk HK, Cai J-P, Chan K-H, Zheng B-J, Wang M. Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of Betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A. J Virol. 2015;89(6):3076–92.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med. 2020;9:1225.

    CAS  PubMed Central  Article  Google Scholar 

  8. 8.

    Woo PC, Lau SK, Chu C-M, Chan K-H, Tsoi H-W, Huang Y, Wong BH, Poon RW, Cai JJ, Luk W-K. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol. 2005;79(2):884–95.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. 9.

    Woo PC, Lau SK, Lam CS, Lau CC, Tsang AK, Lau JH, Bai R, Teng JL, Tsang CC, Wang M. Discovery of seven novel Mammalian and avian coronaviruses in the genus deltacoronavirus supports bat coronaviruses as the gene source of alphacoronavirus and betacoronavirus and avian coronaviruses as the gene source of gammacoronavirus and deltacoronavirus. J Virol. 2012;86(7):3995–4008.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  10. 10.

    Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  11. 11.

    Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;92(6):595–601.

    CAS  PubMed  Article  Google Scholar 

  12. 12.

    Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24(6):490–502.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. 13.

    Pradesh U, Upadhayay PDD, Vigyan PC. Coronavirus infection in equines: a review. Asian J Anim Vet Adv. 2014;9(3):164–76.

    Article  CAS  Google Scholar 

  14. 14.

    Mortola E, Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett. 2004;576(1–2):174–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  15. 15.

    Wang C, Zheng X, Gai W, Zhao Y, Wang H, Wang H, Feng N, Chi H, Qiu B, Li N. MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular immunity in rhesus macaques. Oncotarget. 2017;8(8):12686.

    PubMed  Article  Google Scholar 

  16. 16.

    Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, Tiwari R, Chaicumpa W. Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020;40(1):68–76.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020;9(3):240. https://doi.org/10.3390/pathogens9030240.

    Article  PubMed Central  PubMed  Google Scholar 

  18. 18.

    Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc. 2015;10:845. https://doi.org/10.1038/nprot.2015.053.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450–2.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  20. 20.

    Agriculture, Fisheries and Conservation Department (AFCD). Low-level of infection whit COVID-19 in pet dog. In: Agriculture, Fisheries and Conservation Department (AFCD) (ed). https://www.afcd.gov.hk/english/publications/publications_press/pr2342.html. Accessed 3 Apr 2020.

  21. 21.

    Tilocca B, Soggiu A, Musella V, Britti D, Sanguinetti M, Urbani A, Roncada P. Molecular basis of COVID-19 relationships in different species: a one health perspective. Microbes Infect. 2020;22:218–20.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. 22.

    Junejo Y, Ozaslan M, Safdar M, et al. Novel SARS-CoV-2/COVID-19: origin, pathogenesis, genes and genetic variations, immune responses and phylogenetic analysis. Gene Rep. 2020;20:100752.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    World Health Organization WHO: summary table of SARS cases by country, 1 November 2002–7 August 2003. Wkly Epidemiol Rec Relevé épidémiologique hebdomadaire. 2003;78(35):305–312. https://apps.who.int/iris/handle/10665/232252. Accessed 3 Apr 2020.

  24. 24.

    Lau SK, Woo PC, Li KS, Huang Y, Tsoi H-W, Wong BH, Wong SS, Leung S-Y, Chan K-H, Yuen K-Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci. 2005;102(39):14040–5.

    CAS  PubMed  Article  Google Scholar 

  25. 25.

    Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, Wang H, Crameri G, Hu Z, Zhang H. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005;310(5748):676–9.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Martina BE, Haagmans BL, Kuiken T, Fouchier RA, Rimmelzwaan GF, Van Amerongen G, Peiris JM, Lim W, Osterhaus AD. SARS virus infection of cats and ferrets. Nature. 2003;425(6961):915.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367(19):1814–20.

    CAS  PubMed  Article  Google Scholar 

  28. 28.

    van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3(6):e00473-00412.

    Google Scholar 

  29. 29.

    Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke G-J, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13(10):859–66.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Corman VM, Jores J, Meyer B, Younan M, Liljander A, Said MY, Gluecks I, Lattwein E, Bosch B-J, Drexler JF. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992–2013. Emerg Infect Dis. 2014;20(8):1319.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. 31.

    Annan A, Baldwin H, Corman V, Klose S, Owusu M, Nkrumah E, Badu E, Anti P, Agbenyega O, et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerg Infect Dis. 2013;19:456–9.

    PubMed  PubMed Central  Article  Google Scholar 

  32. 32.

    Hampton T. Bats may be SARS reservoir. JAMA. 2005;294(18):2291.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Kim Y-I, Kim S-G, Kim S-M, Kim E-H, Park S-J, Yu K-M, Chang J-H, Kim EJ, Lee S, Casel MAB. Infection and rapid transmission of SARS-CoV-2 in ferrets. Cell Host Microbe. 2020;27:704–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020. https://doi.org/10.1016/j.cmi.2020.03.026.

    Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol. 2020;30:1346–51.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. 36.

    Ji W, Wang W, Zhao X, Zai J, Li X. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. J Med Virol. 2020.

  37. 37.

    Zhou H, Chen X, Hu T, Li J, Song H, Liu Y, Wang P, Liu D, Yang J, Holmes EC. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein. Curr Biol. 2020;30:2196–203.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. 38.

    Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94:e00127-20.

    PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Khailany RA, Safdar M, Ozaslan M. Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020;19:100682.

    PubMed  PubMed Central  Article  Google Scholar 

  40. 40.

    Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020. https://doi.org/10.1016/j.jinf.2020.02.028.

    Article  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Jurgiel J, Filipiak KJ, Szarpak Ł, Jaguszewski M, Smerka J, Dzieciątkowski T. Do pets protect their owners in the COVID-19 era? Med Hypotheses. 2020;142:109831.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  42. 42.

    Chini M. Coronavirus: Belgian cat infected by owner. The Brussels Times. 2020. https://www.brusselstimes.com/all-news/belgium-all-news/103003/coronavirus-belgian-woman-infected-her-cat/. Accessed 3 Apr 2020.

  43. 43.

    Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu N-H, Nitsche A. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. 44.

    Van den Brand J, Haagmans BL, Leijten L, van Riel D, Martina BE, Osterhaus A, Kuiken T. Pathology of experimental SARS coronavirus infection in cats and ferrets. Vet Pathol. 2008;45(4):551–62.

    PubMed  Article  Google Scholar 

  45. 45.

    Kim A. Cats and dogs abandoned at the start of the coronavirus outbreak are now starving or being killed. CNN. 2020. https://edition.cnn.com/2020/03/15/asia/coronavirus-animals-pets-trnd/index.html. Accessed 3 Apr 2020.

  46. 46.

    Mallapaty S. Coronavirus can infect cats-dogs, not so much. Nature. 2020. https://doi.org/10.1038/d41586-020-00984-8.

    Article  PubMed  Google Scholar 

  47. 47.

    World Organization for Animal Health OIE. Immediate notification. https://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=33832. Accessed 3 Apr 2020.

  48. 48.

    Decaro N, Lorusso A. Novel human coronavirus (SARS-CoV-2): a lesson from animal coronaviruses. Vet Microbiol. 2020;244(2020):108693. https://doi.org/10.1056/NEJM199908193410802.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Tilocca B, Soggiu A, Sanguinetti M, Babini G, De Maio F, Britti D, Zecconi A, Bonizzi L, Urbani A, Roncada P. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19. Microbes Infect. 2020;22:182–7.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Tilocca B, Soggiu A, Sanguinetti M, Musella V, Britti D, Bonizzi L, Urbani A, Roncada P. Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Microbes Infect. 2020;22:188–94.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  51. 51.

    Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, Liu SS, Zhang NN, Li XF, Xiong R, Guo Y, Deng YQ, Huang WJ, Liu Q, Liu QM, Shen YL, Zhou Y, Yang X, Zhao TY, Fan CF, Zhou YS, Qin CF, Wang YC. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 2020. https://doi.org/10.1016/j.chom.2020.05.020.

    Article  PubMed  PubMed Central  Google Scholar 

  52. 52.

    Lutz C, Maher L, Lee C, Kang W. COVID-19 preclinical models: human angiotensin-converting enzyme 2 transgenic mice. Hum Genom. 2020;14:20. https://doi.org/10.1186/s40246-020-00272-6.

    CAS  Article  Google Scholar 

  53. 53.

    Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. J Virol. 2020. https://doi.org/10.1128/JVI.00127-20.

    Article  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Ji W, Wang W, Zhao X, Zai J, Li X. Cross-species transmission of the newly identified coronavirus 2019-nCoV. J Med Virol. 2020;92(4):433–40.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. 55.

    Buonavoglia C, Decaro N, Martella V, Elia G, Campolo M, Desario C, Castagnaro M, Tempesta M. Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis. 2006;12(3):492.

    PubMed  PubMed Central  Article  Google Scholar 

  56. 56.

    Jaimes JA, Millet JK, Stout AE, André NM, Whittaker GR. A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses. Viruses. 2020;12(1):83.

    CAS  PubMed Central  Article  PubMed  Google Scholar 

  57. 57.

    Zhang Q, Zhang H, Huang K, Yang Y, Hui X, Gao J, et al. SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation, bioRxiv. 2020. https://doi.org/10.1101/2020.04.01.021196.

  58. 58.

    Halfmann PJ, Hatta M, Chiba S, Maemura T, Fan S, Takeda M, Kinoshita N, Hattori S-I, Sakai-Tagawa Y, Iwatsuki-Horimoto K. Transmission of SARS-CoV-2 in domestic cats. N Engl J Med. 2020;383:592–4.

    PubMed  Article  Google Scholar 

  59. 59.

    Law T, Leung H. A tiger at the Bronx Zoo has tested positive for coronavirus. TIME. 2020. https://time.com/5815939/tiger-bronx-zoo-positive-coronavirus/. Accessed 3 Apr 2020.

  60. 60.

    Centers for Disease Control and Prevention CDC. Coronavirus disease 2019 (COVID-19). If you have animals. https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/pets.html. Accessed 3 Apr 2020.

  61. 61.

    Centers for Disease Control and Prevention CDC. Confirmation of COVID-19 in two pet cats in New York. https://www.cdc.gov/media/releases/2020/s0422-covid-19-cats-NYC.html. Accessed 3 Apr 2020.

  62. 62.

    World Organization for Animal Health OIE. Immediate notification. https://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=34443&newlang=en. Accessed 3 Apr 2020.

  63. 63.

    Jackwood MW. What we know about avian coronavirus infectious bronchitis virus (IBV) in poultry and how that knowledge relates to the virus causing COVID-19 in humans. Associação Portuguesa de Ciência Avícola APCA. 2020. http://www.apcapt.com/what-we-know-about-avian-coronavirus-infectious-bronchitis-virus-ibv-in-poultry-and-how-that-knowledge-relates-to-the-virus-causing-covid-19-in-humans/. Accessed 3 Apr 2020.

  64. 64.

    Chen J. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses. Microbes Infect. 2020;22:69–71.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  65. 65.

    Ozaslan M, Safdar M, Kilic IH, Khailany RA. Practical measures to prevent COVID-19: a mini-review. J Biol Sci. 2020;20:100–2.

    Article  Google Scholar 

  66. 66.

    Leroy EM, Gouilh MA, Brugère-Picoux J. The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic. One Health. 2020. https://doi.org/10.1016/j.onehlt.2020.100133.

    Article  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Stand van zaken onderzoek COVID-19 naar nertsenbedrijven. (Ministerie van Landbouw, Natuur em Voedselkwaliteit eds.). https://www.rijksoverheid.nl/documenten/brieven/2020/05/19/stand-van-zaken-onderzoek-covid-19-naar-nertsenbedrijven. Accessed 14 Aug 2020.

Download references

Acknowledgements

We would like to thank Dr. Amir Ghorbani of The Ohio State University and João Inácio Magalhães Duarte, for his critical comments on this paper. We gratefully acknowledge the authors, originating, and submitting laboratories of the sequences from the GISAID’s EpiCoV™ Database, on which part of the phylogenetic tree reconstruction is based.

Funding

Not applicable.

Author information

Affiliations

Authors

Contributions

The initial writing was carried out by SST and PMD; the other authors contributed to the complementation, critical review, and final of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Sina Salajegheh Tazerji.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Salajegheh Tazerji, S., Magalhães Duarte, P., Rahimi, P. et al. Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review. J Transl Med 18, 358 (2020). https://doi.org/10.1186/s12967-020-02534-2

Download citation

Keywords

  • Coronavirus
  • COVID-19
  • SARS-CoV-2
  • Pandemic
  • Zoonoses
  • Pet animals
  • Animals
  • Epidemiology
  • One Health